№ lp_1_2_34744
File format: docx
Character count: 8489
File size: 93 KB
Final proposal for the lease of office space, including pricing details, submission instructions, and conditions for leasing office space in Raleigh, North Carolina.
Year:
2024
Region / City:
Raleigh
Theme:
Office Space Leasing
Document Type:
Proposal
Agency / Organization:
North Carolina Department of Revenue
Author:
Sam Tucker
Target Audience:
Proposers
Effective Date:
October 17, 2024
Deadline for Proposal Submission:
October 23, 2024 at 4:00 PM ET
Electronic Submission Portal:
NC eProcurement Electronic Vendor Portal
Proposal Number:
92-966-FINAL
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Jurisdiction:
California, United States
Document Type:
Contractual Attachments / Bid Submission Forms
Related Laws:
California Public Contract Code (PCC) Sections 10365.5, 10410, 10411, 10476, 10477, 10478, 10490; Government Code Sections 1090 et seq., 87100 et seq.; California Rules of Court 10.103, 10.104
Organization:
Judicial Council of California
Purpose:
Submission of proposals, certifications, and acceptance of contract terms
Attachments Included:
3 – Proposer’s Acceptance, 4 – Darfur Contracting Act Certification, 5 – General Certifications Form, 6 – Technical & Cost Proposal Submission Form
Target Audience:
Contractors and firms bidding on Judicial Council contracts
Dates of Program/Proposal:
November 15 – 20, 2026; November 29 – December 4, 2026
Year:
2026
Region / City:
California
Subject:
Contract Terms and Conditions Acceptance
Document Type:
Form
Organization / Institution:
Judicial Council of California
Author:
Judicial Council of California
Target Audience:
Proposers submitting bids to the Judicial Council
Period of Validity:
2026
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2024
Region / City:
North Carolina
Topic:
Public Procurement
Document Type:
Proposal
Agency / Institution:
North Carolina Department of Health and Human Services
Author:
Drew Middleton
Target Audience:
Vendors / Proposers
Effective Date:
January 10, 2024
Submission Deadline:
January 16, 2024
Proposal Type:
Final Proposal
Proposal Submission Method:
Electronic submission only via North Carolina eProcurement portal
Meeting Date:
January 10, 2024
Additional Details:
Proposal must include utilities, janitorial services, and water/sewer costs, if applicable
Description:
Document is an official final proposal notification and instructions for proposers, outlining the terms and submission requirements for a public procurement process regarding office space leasing.
Year:
2014
Region / City:
General Assembly
Topic:
Social Justice
Document Type:
Guide
Organ / Institution:
Unitarian Universalist Association
Author:
Unitarian Universalist Association
Target Audience:
Delegates at General Assembly
Period of Validity:
2014
Approval Date:
2014
Date of Modifications:
May 22, 2014
Year:
2024
Region / City:
Texas, Austin
Topic:
Student Accident and Athletic Insurance
Document Type:
Proposal Invitation
Organization / Institution:
TASB Benefits Cooperative
Author:
First Public, LLC
Target Audience:
Public school districts and local governments in Texas
Period of Action:
2024-2025
Approval Date:
Not specified
Date of Changes:
Not specified
Document Type:
Request for Proposal Appendix
Section:
Appendix 6
Subject:
Business Profile and Organizational Experience Information
Purpose:
Proposer qualification and evaluation requirements
Organization Referenced:
ETF
Content Type:
Questionnaire and disclosure requirements
Primary Topics:
Corporate structure, organizational background, regulatory history, litigation disclosure, staffing qualifications, quality control procedures, job categories
Required Respondents:
Proposers submitting responses to the RFP
Key Roles Referenced:
Lead Account Manager, Account Manager, Administrative Staff, Recruiters
Disclosure Period:
Past five (5) calendar years for investigations, litigation, and contract history
Evaluation Body:
Evaluation committee and the Department
Related Appendices:
Appendix 6, Appendix 7
Submission Requirements:
Written responses with supporting documents and labeled attachments
Year:
2025
Region / City:
UK, Aston University
Theme:
Social Science
Document Type:
Guidance Notes
Institution:
Aston University
Author:
ESRC Festival Team
Target Audience:
Academic and Research Staff, PhD Students
Period of Implementation:
From Saturday 18th October to Saturday 8th November 2025
Approval Date:
Not specified
Date of Changes:
Not specified
KHG Housing Strategy and Enabling Subgroup Meeting Notes, 13th January 2026, 2:00 – 3:30pm, on Teams
Year:
2026
Region / City:
Kent & Medway
Topic:
Housing Strategy and Affordable Housing
Document Type:
Meeting Notes
Organization:
Kent Housing Group (KHG)
Author:
N/A
Target Audience:
KHG members, local authorities, housing professionals
Period of Effectiveness:
N/A
Approval Date:
13th January 2026
Date of Changes:
N/A
Year:
2024
Region / City:
Australia
Topic:
Medicinal Product Registration
Document Type:
Submission Report
Agency:
Therapeutic Goods Administration (TGA)
Author:
GlaxoSmithKline Australia
Target Audience:
Medical Practitioners
Treatment Phase:
Initial Treatment
Indication:
Myelofibrosis, including primary, post-polycythaemia vera, and post-essential thrombocythaemia myelofibrosis
Approval Status:
Pending
Date of Submission:
May 2024
Date of Approval:
Not yet approved
Background:
Momelotinib is currently approved in the UK, US, Japan, and the EU.
Description:
Clinical submission for listing momelotinib under the Australian PBS for the treatment of myelofibrosis in patients with moderate to severe anaemia.
Year:
2019
Region / City:
San Clemente, CA
Subject:
Criminal Law
Document Type:
Course Outline
Institution:
Grossmont College
Author:
Richard Michelson, James Zuffoletto, M. R. Lippman
Target Audience:
Students of Criminal Justice
Period of Application:
Fall Semester 2019
Approval Date:
December 13, 2019
Location:
Academic Senate Conference Room (AS 125)
Year:
2019
Region / City:
Long Beach, California
Subject:
Executive Committee Meeting Minutes
Document Type:
Meeting Minutes
Organization / Institution:
California State University, Long Beach (CSULB)
Author:
J. Pandya, N. Hultgren, M. Aliasgari, N. Meyer-Adams, C. Cummings, P. Hung, D. Stewart, N. Schürer, K. Janousek, E. Klink, P. Soni, J. Phillips, D. Hamm, K. Bonetati, J. Hamilton, S. Apel, B. Jersky, J. Cormack, A. Kinsey
Target Audience:
Faculty, Academic Senate, Executive Committee members
Period of Validity:
Not specified
Approval Date:
August 27, 2019
Amendment Date:
Not specified
Note:
Year
Year:
2026
Region / City:
Northport, New York
Topic:
Roof Replacement, Architectural Design
Document Type:
Design Submission Instructions
Institution:
Department of Veterans Affairs
Author:
Department of Veterans Affairs
Target Audience:
Architects/Engineers involved in VA projects
Effective Period:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2022
Region / City:
Australia
Subject:
Pharmacology, Pharmaceutical Benefits Scheme (PBS)
Document Type:
Submission
Organization / Institution:
Sanofi-Aventis Australia Pty Ltd
Author:
Not specified
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Not specified
Approval Date:
3 June 2022
Date of Changes:
Not specified
Contextual Description:
A regulatory submission detailing the request for listing of dupilumab in new forms for treating severe atopic dermatitis and uncontrolled severe asthma in pediatric patients under the PBS.
Year:
2013
Region / City:
Hillston
Topic:
Annual General Meeting, Water Policy, Agriculture, Irrigation
Document Type:
Meeting Minutes
Organization:
Lachlan Valley Water Inc
Author:
Dennis Moxey (Chairman)
Target Audience:
Members of Lachlan Valley Water Inc, Stakeholders in Water and Irrigation Policy
Period of Action:
12 September 2013
Approval Date:
12 September 2013
Date of Changes:
Not specified
Note:
Year
Document Type:
Policy Template
Governing Body:
State Water Board
Intended Audience:
Public Water System Operators
Service Connections Covered:
Single-family, Multifamily, Commercial, Industrial, Agricultural, Landscape
Legal Authority:
Operating rules / Ordinance / Board resolution / Bylaw
Certification Requirements:
ANSI/DDW recognized cross-connection control specialist
Inspection Frequency:
Initial and ongoing hazard assessments
Backflow Prevention Requirements:
Inventory, testing, maintenance, corrective actions
Incident Response:
Reporting and notification procedures
Public Outreach:
Education methods for customers, staff, and community
Year:
2022
Region / City:
Australia
Theme:
Oncology, Medical Treatment
Document Type:
Pharmaceutical Submission
Organization / Institution:
Bristol-Myers Squibb Australia Pty Ltd
Author:
Not specified
Target Audience:
Medical professionals, Oncologists
Period of validity:
Ongoing
Approval Date:
4 July 2018
Date of Changes:
Not specified
Note:
Contextual Description
Year:
2021
Region / City:
Australia
Topic:
Atopic dermatitis treatment, medication submission
Document Type:
Submission report
Organization / Institution:
Sanofi-Aventis Australia Pty Ltd
Author:
Sanofi-Aventis
Target Audience:
Medical professionals, regulatory authorities
Action Period:
Ongoing treatment evaluation
Approval Date:
17 August 2021
Modification Date:
Not specified
Background:
Dupilumab registration history
Clinical Claim:
Dupilumab has superior efficacy compared to standard care for children with severe atopic dermatitis
Episodicity:
Chronic
Severity:
Severe
Condition:
Atopic dermatitis
PBS Indication:
Chronic severe atopic dermatitis
Prescriber Type:
Medical practitioners, dermatologists, clinical immunologists
Treatment Phase:
Initial, continuing
Population Criteria:
Children aged 6 to 11 years, specific weight ranges
Comparator:
Placebo
Outcomes:
EASI-75, IGA 0 or 1 at Week 16, improvement in itch score
Dosing:
Tiered by body weight
Cost:
$1,754.28–$3,380.91
Price:
Published price for maximum quantity
Form:
Pre-filled syringe
Medical Information:
Dupilumab 300 mg/2 mL, 200 mg/1.14 mL
Note:
Comparator
Standard of care (Placebo)
Source:
PBAC submission